Henry Schein Inc
NASDAQ:HSIC

Watchlist Manager
Henry Schein Inc Logo
Henry Schein Inc
NASDAQ:HSIC
Watchlist
Price: 71.06 USD -0.85% Market Closed
Market Cap: 8.9B USD
Have any thoughts about
Henry Schein Inc?
Write Note

Henry Schein Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Henry Schein Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Henry Schein Inc
NASDAQ:HSIC
Income from Continuing Operations
$303m
CAGR 3-Years
-21%
CAGR 5-Years
-9%
CAGR 10-Years
-5%
Cardinal Health Inc
NYSE:CAH
Income from Continuing Operations
$1.3B
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
1%
Adapthealth Corp
NASDAQ:AHCO
Income from Continuing Operations
-$211.3m
CAGR 3-Years
-50%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Patterson Companies Inc
NASDAQ:PDCO
Income from Continuing Operations
$154.9m
CAGR 3-Years
-1%
CAGR 5-Years
24%
CAGR 10-Years
-1%
Mckesson Corp
NYSE:MCK
Income from Continuing Operations
$2.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
6%
Cencora Inc
NYSE:COR
Income from Continuing Operations
$1.5B
CAGR 3-Years
-1%
CAGR 5-Years
13%
CAGR 10-Years
18%
No Stocks Found

Henry Schein Inc
Glance View

Economic Moat
None
Market Cap
8.9B USD
Industry
Health Care

In the evolving landscape of healthcare distribution, Henry Schein Inc. has carved out a robust niche, establishing itself as a pivotal player in delivering essential products and services. Founded in 1932, the company initially responded to the growing need for medical supplies with a simple commitment to customer service and innovation. Today, the company profiles as the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, alongside its veterinary arm. It services a global footprint, channeling its efforts into dental, medical, and animal health sectors. The company's sprawling network deploys a vast array of products—from consumables to equipment—to a multitude of healthcare professionals, accentuating its integral role in the clinical toolkit. Henry Schein's revenue engine thrives on a meticulously crafted business model that combines the breadth of a comprehensive catalog with targeted value-added services. Its diverse product offerings span dental implants, vaccines, pharmaceuticals, and surgical supplies, delivered through direct sales and sophisticated logistical frameworks. Moreover, Henry Schein supplements its product lines with a suite of services, including practice management solutions and e-commerce platforms, that streamline operations for practitioners and enhance client loyalty. Strategic partnerships and acquisitions show the company's commitment to innovation, driving efficiencies and expanding its reach. This continuous adaptation keeps Henry Schein at the forefront of healthcare trends, ensuring steady streams of income flowing from both longstanding relationships and new market opportunities.

HSIC Intrinsic Value
102.49 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Henry Schein Inc's Income from Continuing Operations?
Income from Continuing Operations
303m USD

Based on the financial report for Sep 28, 2024, Henry Schein Inc's Income from Continuing Operations amounts to 303m USD.

What is Henry Schein Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
-5%

Over the last year, the Income from Continuing Operations growth was -34%. The average annual Income from Continuing Operations growth rates for Henry Schein Inc have been -21% over the past three years , -9% over the past five years , and -5% over the past ten years .

Back to Top